Total Funding
33
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
766884
DMI Life Sciences develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation.
Michael Macaluso: Chief Executive Officer, founder and DirectorPast Role: Page International Communications, Owner
Bruce G. Miller: President & CEO
About the Company
DMI Life Sciences, Inc. is a biotechnology company. It discovers and develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation. The company is focused on immunologic, vascular and CNS diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer’s disease, asthma, and cancer.
DMI Life
Sciences, Inc. was founded by David Bar and Michael Macaluso in 2009; and is headquartered in Greenwood Village, Colorado.
